Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder

International Psychogeriatrics

Volumn 20, Issue 2, 2008, Pages 309-327

  Raskin, Joel ^a   Xu, Jimmy Y ^a   Kajdasz, Daniel K ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Depression; Duloxetine; Elderly; Onset of action

Indexed keywords

DULOXETINE; PLACEBO;

AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG WITHDRAWAL; ELDERLY CARE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NAUSEA; PAIN; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; VISUAL ANALOG SCALE; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; THIOPHENES; TIME FACTORS;

EID: 38949091722     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610207005649     Document Type: Article

References (43)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: American Psychiatric Association.
2. Benkert, O. et al. (2006). Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder. Journal of Clinical Psychopharmacology, 26, 75-78.
3. Brannan, S. K., Mallinckrodt, C. H., Detke, M. J., Watkin, J. G. and Tollefson, G. D. (2005). Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies. Journal of Psychiatric Research, 39, 161-172.
4. Bymaster, F. P. et al. (2001). Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology, 25, 871-880.
5. DeLoach, L. J., Higgins, M. S., Caplan, A. B. and Stiff, J. L. (1998). The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesthesia and Analgesia, 86, 102-106.
6. Depression Guideline Panel (1993). Clinical Practice Guideline Number 5: Depression in Primary Care. Rockville, MD: U.S. Department of Health and Human Services, Agency for Health Policy and Research.
7. Detke, M. J., Lu, Y., Goldstein, D. J., Hayes, J. R. and Demitrack, M. A. (2002). Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. Journal of Clinical Psychiatry, 63, 308-315.
8. Driscoll, H. C. et al. (2005). Late-onset major depression: clinical and treatment-response variability. International Journal of Geriatric Psychiatry, 20, 661-667.
9. Entsuah, R., Derivan, A. and Kikta, D. (1998). Early onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients. Clinical Therapeutics, 20, 517-526.
10. Flint, A. J. and Rifat, S. L. (1997). Effect of demographic and clinical variables on time to antidepressant response in geriatric depression. Depression and Anxiety, 5, 103-107.
11. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
12. Frank, E. et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48, 851-855.
13. Georgotas, A., McCue, R. E., Cooper, T. B., Nagachandran, N. and Friedhoff, A. (1989). Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine. Psychiatry Research, 28, 1-9.
14. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery, and Psychiatry, 23, 56-62.
15. Hirschfeld, R. M., Mallinckrodt, C., Lee, T. C. and Detke, M. J. (2005). Time course of depression-symptom improvement during treatment with duloxetine. Depression and Anxiety, 21, 170-177.
16. Katz, M. M., Koslow, S. H. and Frazer, A. (1996). Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs. Depression and Anxiety, 4, 257-267.
17. Katz, M. M. et al. (1997). Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology, 17, 110-115.
18. Katz, M. M. et al. (2004). Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology, 29, 566-579.
19. Katz, M. M., Bowden, C. L., Berman, N. and Frazer, A. (2006). Resolving the onset of antidepressants' clinical actions: critical for clinical practice. Journal of Clinical Psychopharmacology, 26, 549-553.
20. Leon, A. C. et al. (2001). An ideal trial to test differential onset of antidepressant effect. Journal of Clinical Psychiatry, 62, 34-36.
21. Mitchell, A. J. (2006). Two-week delay in onset of action of antidepressants: new evidence. British Journal of Psychiatry, 188, 105-106.
22. Mulsant, B. H. et al. (2006). What is the optimal duration of a short-term antidepressant trial when treating geriatric depression? Journal of Clinical Psychopharmacology, 26, 113-120.
23. Nelson, J. C., Mazure, C. M., Bowers, M. B. Jr. and Jatlow, P. I. (1991). A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Archives of General Psychiatry, 48, 303-307.
24. Nierenberg, A. A. et al. (2007). Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Current Medical Research Opinion, 23, 401-416.
25. Papakostas, G. I., Perlis, R. H., Scalia, M. J., Petersen, T. J. and Fava, M. (2006). A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. Journal of Clinical Psychopharmacology, 26, 56-60.
26. Parker, G. (1996). On brightening up: triggers and trajectories to recovery from depression. British Journal of Psychiatry, 168, 263-264.
27. Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L. and DeKosky, S. T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1133-1142.
28. Posternak, M. A. and Zimmerman, M. (2005). Is there a delay in the antidepressant effect? A meta-analysis. Journal of Clinical Psychiatry, 66, 148-158.
29. Raskin, J. et al. (2007). Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. American Journal of Psychiatry, 164, 900-909.
30. Reynolds, C. F. III (1997). Treatment of major depression in later life: a life cycle perspective. Psychiatric Quarterly, 68, 221-246.
31. Roose, S. P. and Sackeim, H. A. (2002). Clinical trials in late-life depression: revisited. American Journal of Geriatric Psychiatry, 10, 503-505.
32. Roose, S. P. et al. (2004). Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. American Journal of Psychiatry, 161, 2050-2059.
33. Schatzberg, A. and Roose, S. (2006). A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. American Journal of Geriatric Psychiatry, 14, 361-370.
34. Staab, J. P. and Evans, D. L. (2000). Efficacy of venlafaxine in geriatric depression. Depression and Anxiety, 12 (Suppl. 1), 63-68.
35. Stahl, S. M., Nierenberg, A. A. and Gorman, J. M. (2001). Evidence of early onset of antidepressant effect in randomized controlled trials. Journal of Clinical Psychiatry, 62, 17-23.
36. Stassen, H. H., Angst, J. and Delini-Stula, A. (1997). Delayed onset of action of antidepressant drugs? Survey of recent results. European Psychiatry, 12, 166-176.
37. Taylor, M. J., Freemantle, N., Geddes, J. R. and Bhagwagar, Z. (2006). Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives of General Psychiatry, 63, 1217-1223.
38. Thompson, C. (1999). Mirtazapine versus selective serotonin reuptake inhibitors. Journal of Clinical Psychiatry, 60, 18-22.
39. Thompson, W. L., Brunelle, R. L., Enas, G. G. and Simpson, P. J. (1987). Routine laboratory tests in clinical trials: interpretation of results. Journal of Clinical Research and Drug Development, 1, 95-119.
40. Walsh, B. T. and Sysko, R. (2005). Placebo control groups in trials of major depressive disorder among older patients. Journal of Clinical Psychopharmacology, 25, S29-S33.
41. Whyte, E. M. et al. (2004). Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs and Aging, 21, 531-554.
42. Yesavage, J. A. et al. (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 37-49.
43. Zigmond, A. S. and Snaith, R. P. (1983). The hospital anxiety and depression scales. Acta Psychiatrica Scandinavica, 67, 361-370.